Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19960 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197539 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-01-24 | 2020-02-26 | 104353 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-04-02 | 2020-05-01 | 110691 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106913 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195459 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194077 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2025-12-18 | 2025-12-19 | 274658 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43141 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112382 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2024-02-08 | 2025-01-30 | 218940 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Actual shortage | 2025-10-16 | 2025-10-16 | 269664 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104347 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-16 | 2021-01-28 | 120497 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-07-16 | 2020-07-23 | 120500 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2025-10-30 | 2025-10-30 | 270675 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2017-04-03 | 2017-05-23 | 5197 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110779 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258691 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2025-05-27 | 2025-05-27 | 258359 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| COUGH SYRUP WITH CODEINE | 30MG 3.3MG 100MG | SYRUP SYRUP | Reversed | 2025-05-28 | 2025-06-03 | 258600 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 |